Kate Jeffrey

Kate Jeffrey

Company: Moderna

Job title: Vice President - Immune Therapeutics Discovery


Harnessing mRNA-encoded Cytokines as Immune Therapeutics for a Focused Immune Response 4:10 pm

Engineered cytokines encoded by nucleoside modified mRNA and delivered in LNPs enables tailored and focused immune therapeutics Multiplexing a myriad of cytokines by the mRNA/LNP platform allows next-generation broad immunomodulation for clinical benefit Providing examples of harnessing mRNA technology for manipulating the immune response via cytokines for autoimmune and inflammatory diseaseRead more

day: Conference Day One

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.